“…These compounds have been shown to play a role in the depression of respiration in newborn animals, an effect that is mitigated or reversed by naloxone [3, 4, 7-9]. Elevated levels of endorphins have been documented in premature infants [10], asphyx iated newborns [11,12], infants with severe apneic episodes [13], and in stressed neonates [14], all of whom suffer from disorders of respiratory control. Preliminary studies in human newborns demonstrated that nalox one significantly decreased the incidence of periodic breathing and im proved pneumocardiogram abnormalities in infants with apnea [5,6], The pharmacokinetics of naloxone have been studied in adults and in full-term newborns, but no data are available in premature neonates [15][16][17][18].…”